Application deadline: 31/12/18
VHIO seeks a Staff Scientist in Thoracic Cancer Genomics, under the joint leadership of Enriqueta Felip and Ana Vivancos, Principal Investigators of our Thoracic Tumors and Cancer Genomics Groups, respectively.
As a leading reference in translational cancer science and clinical oncology, with a broad portfolio of clinical trials, we run between 25 – 30 clinical trials in thoracic malignancies at any given time.
Our clinical studies assess novel agents in the pipeline that target a wide spectrum of cancer genes and pathways. These efforts are driven through superb multidisciplinary teamwork and close connectivity between our oncologists and cancer researchers.
More specifically, Cancer Genomics at VHIO not only serves as one of our state-of-the-art Core Technologies, but also carries out its own independent translational research of excellence.
Our lab is equipped with an n-Counter instrument (Nanostring), digital droplet PCR (BEAMing and Bio-Rad), qPCR; MiSeq and HiSeq 2500 (Illumina) sequencers and hardware. Addionally, VHIO’s Molecular Prescreening Program is executed by VHIO’s Cancer Genomics and Molecular Oncology teams.
We are seeking a highly motivated research scientist to join a newly created, dynamic and purely translational laboratory.
Prior experience in NGS and cancer genomics is mandatory and a background in thoracic tumors will be considered favorable.
- PhD in Molecular Biology, Genetics, or any other related field.
- Expertise in cancer genomics, cellular pathways commonly implicated in cancer, the clinical application of next generation sequencing.
- Detail oriented with a capacity to critically analyze and interpret scientific data.
- The successful candidate will have good communication skills, with excellent spoken and written English, and the capacity to work independently as well as part of a team.
This is a full-time position and annual gross salary will be considered according to the profile, experience, and professional merits of the candidate.
Please send a CV and cover letter to email@example.com, specifying “Ref. 20/2018” in the subject line of your email.
Under the leadership of Josep Tabernero, the Vall d’Hebron Institute of Oncology (VHIO), created by José Baselga in 2006, has established itself as a comprehensive cancer center of proven excellence internationally. It is thanks to Josep Tabernero’s directorship and VHIO’s optimal organizational structure based on a purely multidisciplinary and translational model that VHIO talents continue to anticipate and tackle the many unresolved questions in combatting this multifaceted and heterogeneous disease.
Located within the Vall d’Hebron Barcelona Hospital Campus, our researchers closely collaborate and interact with Vall d’Hebron physician-scientists. Translational science and clinical research are therefore tightly connected which promotes superb interaction and teamwork which, in turn, accelerates the bench-bedside-bed cycle of knowledge. This privileged environment affords VHIO direct access to patients as well as the entire spectrum of oncology professionals who care for them, and a second-to-none appreciation of how cancer science can translate into more powerful, targeted treatments and better practice for the care of patients.
VHIO’s pioneering model and programs, coupled with its belief in combining strengths through cross-border collaborations, continue to spur advances in reversing cancer resistance, halting metastatic spread, and more effectively treating even the most undruggable tumor types.
VHIO’s translation toward precision oncology: http://www.vhio.net.